Long-Term Assets: The sum of all assets classified as non-current.
Arbutus Biopharma Corporation (ABUS) had Long-Term Assets of $0.27M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.53M |
|
$-7.74M |
|
-- |
|
$0.53M |
|
$9.19M |
|
$-8.66M |
|
$0.92M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-8.66M |
|
$-8.65M |
|
191.78M |
|
191.78M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$97.44M |
|
$0.14M |
|
|
Long-Term Assets |
$0.27M |
$97.71M |
|
$5.18M |
|
-- |
|
$15.13M |
|
$20.31M |
|
$77.40M |
|
$77.40M |
|
$77.40M |
|
191.95M |
|
| Cash Flow Statement Financials | |
$-34.96M |
|
$16.94M |
|
$4.08M |
|
$36.33M |
|
$22.41M |
|
$-13.92M |
|
$5.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1636.86% |
|
-1636.86% |
|
-- |
|
-1463.52% |
|
-1463.52% |
|
$-34.95M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.58 |
|
153.97 |
|
-10.00% |
|
-10.00% |
|
-7.92% |
|
-10.00% |
|
$0.40 |
|
$-0.18 |
|
$-0.18 |
|